?
???? 2 2 6
???? ??????????????? ( W 6 ) 。
???? ?? ( 6 ) ,? ,?? ,???? ,????????????? ,???????、????????。
???? ??? ( 63 )? ,???? ,???????、????????。 2 q @
???? : 1671 - 7554 (2009) 09 - 0011 - 03
2 型 糖 尿 病 患 者 轻 度 认 知 功 能 障 碍 和
血 清 AGEs 水 平 的 关 系
?? ,??? ,?? ,?? ,??? ,??? ,???
(?????????????? , ?? 250021)
?? :?? ?? 2???????????????????????? (AGEs)????? 。?? ? 2??
???? 62????????????? 30 ? ,????????? 32 ? ,?????? 30 ?。? ELISA??
??? AGEs ,????????? 、??、?? 、?????、24 h?????????。?? ???????
??? AGEs??????????????? ( P < 0.05)?????? ( P < 0. 01) ;2 ?????? MMSE??
???、?????、??????、???????? AGEs ?????? ( r = - 0. 315 , - 0. 276 , - 0. 384 ,
- 0. 384 , - 0.282) 。?? ?? AGEs??? 2????????????????????? ,??????
?????。
??? :2???? ;???????? ;?????? ;?????
????? :R587.1 ????? :A
Correlation between mild cognitive impairment and advanced glycosylation
end product level in type 2 diabetic patients
GAO Xia , ZHANG Hong2xia , GAO Ling , CHEN Qing , J IANGXiu2yun , GUAN Qing2bo , ZHAO Jia2jun
(Department of Endocrinology , Provincial Hospital Affiliated to Shandong University , Jinan 250021 , China)
Abstra ct : Objective To determine the relationship between advanced glycosylation end products (AGEs) and mild cognitive im2
pairment in type 2 diabetic patients. Methods Based on the Mini2Mental State Examination (MMSE) score , type 2 diabetic pa2
tients were divided into two groups : one group with 30 cases of cognitive impairment and the other with 32 cases of non2cognitive
impairment. 30 normal participants served as the control group. AGEs was measured by ELISA in all subjects , also HbA1 c ,
blood lipids , uric acid , fibrinogen , urinary albumin of 24 hours , and other biochemical indicators were measured in all subjects.
Results The AGEs level of the cognitive impairment group was significantly higher than that of the non2cognitive impairment
group ( P < 0.05) and the control group ( P <0. 01) . MMSE score of patients with type 2 diabetes negatively correlated with age ,
durationof diabetes , HbA1 c , body mass index , and serum levels of AGEs ( r = - 0. 315 , - 0. 276 , - 0. 384 , - 0. 384 ,
- 0. 282) . Conclusions Increased AGEs may be an important risk factor for cognitive impairment in type 2 diabetic patients.
AGEs may be involved in the pathogenesis of diabetic encephalopathy.
Key words: Type 2 diabetes mellitus ; Advanced glycosylation end products ; Cognitive impairment ; Diabetic encephalopathy
??????????????? ,????
?????????? ,??????、????、
?????、?????、???????????
??。?????????????????。?
? ,????????? ,???????????
???? ,??????????????[ 1] 。?
????????????????????? ,
??????????????[223] 。?????
? 47? ? 9 ?
Vol. 47 No. 9
? ? ? ? ? ? (? ? ?)
JOURNAL OF SHANDONGUNIVERSITY(HEALTH SCIENCES)
2009 ? 9?
Sep. 2009
: 2009 04 1
: 2009 H 0 7
: 197 -
: 19 - E ma il :guan ingbo medmail . com. cn
?
?? 2 ?????????????????
(advanced glycosylation end products , AGEs)????
?????????? ,???? AGEs ????
??????????。
1 ?????
1. 1 ???? 92 ?????????????
??? 2 ??????????????????
???。???????? ,??????、???
????????????。2 ????????
? 1999? WHO???????。???????
????? Petersen ??[4 ] :????????? ,
??????? ;?????? ,????????
??????? ;???????? ;??????
???? ; ???????? (Mini2Mental State
Examination ,MMSE) 24?27?。
????? 3? : ①???????? :?? 2
?????? ,?????????? ,? 30? ,?
?? 12 ? ,? 18? ,51?73 ? ,?? (63. 43 ?6. 39)
? ; ②????????? :2 ?????? ,??
????? (MMSE?? > 27 ?) ,? 32 ? ,???
14? ,? 18 ? ,50?71 ? ,?? (61. 09?5. 57)? ; ③
????? :?30 ? ,???13? ,? 17 ? ,50?70
? ,?? (58. 73 ?5. 98) ? ,?????、???、?
??、????、???????。
?????????????? : ①????
?????????????????????
?、????????、???????、????
??? ; ②?????????????????
?? ,??????????? ; ③???????
??????????????? ; ④?????
?????????、??????????? ,?
??????、????? ; ⑤????? 2???
??????????????。
1. 2 ??
1. 2. 1 ?????? ????????? :?
?、??、??、?????、2 ??????、??
??(???、???、????????) 、???
(??????????、????????) 、??
??????????????????? (??
??、???、???) 。????? (BMI) = ??
? ( )Π?? 。
G ??? ???????? ??
???????? 3 L ,?????? ,? ?
3 000 r/ min?? 15 min(?????? B600 ???
?????? ,???????) ,????? - 60
????? ,??????? ,?????? ELIAS
??? AGEs ,??????????。???Lab2
systems?????? 450 nm ???? OD ? ,??
???? ,???????。AGEs ???????
? Uscnlife ??。
1. 2. 3 ????? 24 h????????? ?
? 1 ???????????? ( TC) 、????
(TG) 、????????? (LDL2C) 、??????
??? ( HDL2C) 、??、????? ( Fib)?????
?? ( HbA1c) 。?? 24 h ? ,??????? 24 h
?????? (MA) ,???????????Orion
Diagnostica ?? ,??????????。?? 24 h
? MA ?????30 mgΠL ??? ( Ⅰ) ,??30 mgΠL
??? ( Ⅱ) 。
1. 3 ????? ????? SPSS 16. 0????
?????。??????????????? ,
???????????? �x ?s ?? ,????
????? ,????? Bonferroni ??、????
?? Games2Howell ?? ;???????χ2 ???
?????。MMSE???????? Spearman ?
??????? , P <0. 05?????????。
2 ? ?
2. 1 ???? ?? 1。???????、??、
??????????????? ( P > 0. 05) 。?
????????BMI、HbA1c、Fib、??、??、24 h
? MA???????????? ,??????
?? ( P > 0. 05) 。??????????????
??????????????? ( P <0. 05) 。
2. 2 ???????? AGEs????? ??
1。???????? AGEs ?????????
???? ,???????? ,?????????
????????? AGEs ??????? ( P <
0. 01 , P < 0. 05) ,?????? ,????????
AGEs ???? ( P <0. 05) 。
2. 3 2????? MMSE ??????????
?? ? Spearman ?????? ,2 ??????
? MMSE??? TC、TG、LDL2C、HDL2C、???、?
???????? ( P ? > 0. 05) ;MMSE ????
?、 、G 、?????? BMI ???? ,??
???????? ,?? 。?? , ? G ?
???( = 6 , < ) 。
12 ? ? ? ? ? ? (? ? ?) 47? 9 ?
kg 2
1. 2. 2 A Es 12 h
m 1 h
HbA1c A Es
2 HbA1c A Es
r 0. 4 4 P 0. 001
?
? 1 ???????????? (�x ?s)
? ?
????
????
( n =30)
?????
????
( n =32)
?????
( n = 30)
?? (?Π?) 12Π18 14Π18 13Π17
?? (?) 63. 43?6. 39 61. 09 ?5. 57 58 . 73 ?5. 98
?? (?) 11. 13?5. 74Δ 9. 21 ?6. 23 ?
????? (?) 7. 43?4. 84 8. 84?4. 97 8. 35?5. 28
HbA1 c( %) 10. 19 ?2. 63 3 3 9. 47 ?2. 45 3 3 4. 90?0. 44
BMI(kgΠm2) 25. 63 ?1. 87 3 3 24. 43 ?2. 37 3 21 . 00 ?2. 94
Fib ( mΠg?L - 1) 3 . 85 ?1. 17 3 3. 39?0. 94 3. 05?0. 59
TC( cΠmmol?L - 1) 5. 20?0. 95 5. 19?1. 32 4. 58?0. 73
TG( cΠmmol?L - 1) 1. 91 ?0 . 58 3 3 1. 90 ?0. 47 3 3 1. 34?0. 27
LDL2C( cΠmmol?L - 1) 2. 94?0. 66 3. 07?0. 80 3 2. 60?0. 43
HDL2C( cΠmmol?L - 1) 1. 37?0. 32 1. 23?0. 28 1. 28?0. 15
24 h? MA(ⅠΠⅡ) 16Π14 3 19Π13 3 26Π4
???( PΠmmHg) 142. 80?24. 02 3 149. 78?22. 55 3 121 . 58 ?14 . 07
???( PΠmmHg) 83. 87?15. 45 85. 31?13. 59 76 . 96 ?7. 46
???( cΠmmol?L - 1) 311. 23?61. 32 293. 12 ?80. 20 268 . 58 ?68 . 21
AGEs (ρΠmg?L - 1) 16. 64 ?6. 45 3 3Δ 11. 70 ?4. 61 3 8. 48?2. 43
3P < 0. 05 , 33P <0. 01 vs ??? ;ΔP <0. 05 vs?????
????
? 2 AGEs?????? MMSΠE??????
? ?
MMSE??
r P
?? (?) - 0. 315 0.013
????? (?) 0. 296 0.019
????? (?) - 0. 384 0.002
BMI(kgΠm2 ) - 0. 282 0.027
HbA1c ( %) - 0. 276 0.030
AGEs(ρΠmg?L - 1) - 0. 384 0.002
3 ? ?
?????????????????[5 ] ,?
?????????[ 6] ,60 ?????? 6 %?
12 %???? ,85 ???????? 20 %?48 %?
???。???? 400 ????? ,??????
???? ,???????[7 ] 。???? ,????
???????????????? ,?????
??????????????????? 3 ? ,
???????? ,????????? (AD)??
?????????? ,???????????
?、AGEs ??、??????????[8 ] 。2 ??
?????????????????????
? ,???????? ,?????、??????
??????。
AGEs?????????????????
?? ,??????????????????? ,
?????。Maillard ???????????? ,
?????????????????????
? ,???? AGEs?? ,?????????。?
????AGEs???????????????
?????。AGEs ?????????????
??[9 ] 。??????? ,?????????
AGEs ?????????????? ,?????
??????? ;?????????? AGEs ?
???????。Spearman ?????? MMSE ?
??AGEs????。??????????AGEs
?? ,??? 2???????????????。
??????????????? ,??????
?????????? ,???????????
??????。???? AGEs ?致??????
??????????? : ①AGEs?? tau ???
Aβ,??AD ??????? ; ②AGEs ?????
??? ,?????????。Takeuchi ?[10 ] ??
??????????????? AGEs????
?? ,?致 BHK21 ???????、??????
? (SH2SY5Y)??、????????、?????
?????? ( N9) ? ? ; ③AGEs ? AGE ??
(RAGE)?? ,?????? ,?????????
???? ,???????? ,???????? ;
④AGEs??????? ,???????????
??? ,???????? ;??????????
????????? ,??????[ 11 ] 。
HbA1c ?????????????????
???? ,?????????? 2?3 ?????
???。????????? ,AGEs? HbA1c ??
?? , ?? AGEs ???????????? ;
MMSE??? HbA1c ???? ,????[12] ???
??? ,?? 2???????????????
????? ,????????????????
???。
Spearman ??????? ,MMSE?????、
?????? BMI ???? ,?????????
? ,???、??、???????。??????
????????。?????????????
?????。????????? ,30 ?????
???????? AGEs?????? ,AGEs ??
???????????[ 3 ] 。????????
?????????? ,????????、???
?????????????? (??? ?)
?? ,? . 2????????????????? AGEs????? 13
1
20
?
[ 6] Mato S , Chevaleyre V , Robbe D , et al. A single in2vivo expo2
sure to Δ92THC blocks endocannabinoid2mediated synaptic
plasticity[J ] . Nat Neurosci , 2004 , 7(6) :5852586.
[7] Mato S , Robbe D , Puente N , et al. Presynaptic homeostatic
plasticity rescues long2term depression after chronic Δ92tetra2
hydrocannabinol exposure [ J ]. J Neurosci , 2005 , 25 (50) :
11619211627.
[8 ] Hoffman A F , Oz M , Caulder T , et al. Functional tolerance
and blockade of long2term depression at synapses in the nucleus
accumbens after chronic cannabinoid exposure[ J ] . J Neurosci ,
2003 , 23 (12) :481524820.
[ 9 ] Wilson , R I , Nicoll R A. Endogenous cannabinoids mediate
retrograde signalling at hippocampal synapses [ J ] . Nature ,
2001 , 410 (6828) :5882592.
[ 10] Kreitzer A C , Regehr W G. Retrograde inhibition of presyn2
aptic calcium influx by endogenous cannabinoids at excitatory
synapses onto Purkinje cells[J ] . Neuron , 2001 , 29(3) :7172
727.
(?? :???)
(??? 13 ? ) ??。Gregg ?[ 14 ] ? Logroscino
?[15 ]???? ,2 ??????????????
?????????????????。?? 15
???? 2?????????????????
?????。???、????????????
?????????????[16] ,???????
???。???????、??????????
?? ,???????????????????
??、???????????????????。
?? ,2????????????????
?、????致???。AGEs?????????
????????????? ,????????
????。?? ,??、?????、HbA1c ? BMI
???? 2???????????????。?
? ,??????、?????????????
? ,? 2??????????????????
??????。
???? :
[1 ] ??? ,???. 2?????????????? [J ] .
????????? ,2006 ,20 (1) :57259.
[ 2] Biessels G, Corkin S. Cerebral complications of diabetes : clin2
ical findings and pathogenetic mechanisms [ J ] . Neth Med ,
1999 , 54(2) :35245.
[3 ] Geert Jan , Biessels H , Lars P. Ageing and diabetes :implica2
tions for brain f unctin[J ] . Neurophysiol , 2002 , 15 (3) :58264.
[4 ] Petersen R , Corsti P. Mild cognitive impairment : transition be2
tween aging and Alzheimer′s disease [J ] . Neurologia , 2000 ,
45 (8) :932101.
[5] Kate V , Allen R , Braim N , et al. The relationship between
type 2 diabetes and cognitive dysfunction: longitudinal studies
[ ] N B 2
havioral Reviews , 2004 , 65 (4) :17223.
[ 6] De Carli C. Mild cognitive impairment : prevalence , prognosis ,
aetiology and treatment [ J ] . Lancet Neurology , 2003 , 28
(10) :13215.
[ 7] ?? .???????? [J ]. ???????? ,2006 ,
13 (10) :11213.
[ 8] Whitmer R , Arenberg D. Type 2 diabetes and risk of cognitive
impairment and dementia [ J ] . Cur Neurol Neurosci Rep ,
2007 , 7(15) :3732380.
[ 9] Sasaki N , Fukatus R , Tsuzuki K, et al. Advanced glycation
end products in Alzheimer′s disease and other neurodegenera2
tive diseases[J ] . AmJ Pathol , 1998 , 15 (3) :114921155.
[ 10] Takeuchi M , Yamagishi S. Possible involvement of advanced
glycation end2products (AGEs) in the pathogenesis of Alzhei2
mer′s disease [ J ] . Curr Pharm Des , 2008 , 14 (10) : 9732
978.
[ 11] Messier C , Award N , Gagnon M. The relationships between
atherosclerosis , heart disease , type 2 diabetes and dementia
[J ] . Neurol Res , 2004 , 26(5) :5672572.
[ 12] ?? ,??? .??????? 2 ?????????
????????? [J ]. ???????? ,2005 ,3
(4) :24225.
[ 13 ] ??? ,??? ,?? . ?????? AGEs?????
????????? [J ] . ??????? ,2006 ,26
(6) :2752276.
[ 14 ] Gregg E W, Yaffe K, CauleyJ A , et al. Is diabetes associat2
ed with cognitive impairment and cognitive decline among old2
er women ? [J ] . Arch Inern Med , 2000 , 160(8) :1742180.
[ 15] Logroscino G, Kang J H , Grodestein F. Prospective study of
type 2 diabetes and cognitive decline in women aged 70281
years[J ]. BMJ , 2004 , 23 (6) :3282341.
[ 16] Gorospe E C , Dave J K. The risk of dementia with increased
body mass index[J ] . Age Aging , 2007 , 36 (9) :23229.
(?? ???)
20 ? ? ? ? ? ? (? ? ?) 47? 9 ?
and their methodological limitations J . euro science iobe :